2023 Q2 Form 10-Q Financial Statement

#000155837023007663 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $36.62M $41.15M
YoY Change -12.14% -2.14%
Cost Of Revenue $26.34M $28.45M
YoY Change -6.07% -5.08%
Gross Profit $10.27M $12.70M
YoY Change -24.62% 5.17%
Gross Profit Margin 28.06% 30.87%
Selling, General & Admin $5.906M $5.664M
YoY Change 0.37% -1.91%
% of Gross Profit 57.49% 44.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $999.0K $1.010M
YoY Change 0.4% 5.1%
% of Gross Profit 9.72% 7.95%
Operating Expenses $5.906M $5.664M
YoY Change 0.37% -1.91%
Operating Profit $4.367M $7.040M
YoY Change -43.62% 11.64%
Interest Expense $992.0K $947.0K
YoY Change 194.36% 342.52%
% of Operating Profit 22.72% 13.45%
Other Income/Expense, Net
YoY Change
Pretax Income $5.359M $7.987M
YoY Change -33.69% 22.5%
Income Tax $1.287M $1.919M
% Of Pretax Income 24.02% 24.03%
Net Earnings $4.072M $6.068M
YoY Change -34.07% 21.75%
Net Earnings / Revenue 11.12% 14.75%
Basic Earnings Per Share $0.33 $0.49
Diluted Earnings Per Share $0.33 $0.49
COMMON SHARES
Basic Shares Outstanding 12.31M 12.31M
Diluted Shares Outstanding 12.31M 12.31M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $64.75M $60.95M
YoY Change -7.57% -13.18%
Cash & Equivalents $17.96M $17.99M
Short-Term Investments $46.79M $42.96M
Other Short-Term Assets $1.673M $1.950M
YoY Change -55.73% -44.29%
Inventory $33.77M $30.24M
Prepaid Expenses
Receivables $15.04M $18.68M
Other Receivables $0.00 $0.00
Total Short-Term Assets $115.2M $111.8M
YoY Change -7.6% -6.46%
LONG-TERM ASSETS
Property, Plant & Equipment $27.12M $27.91M
YoY Change -7.93% -6.63%
Goodwill $23.74M $23.74M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $12.20M $12.20M
YoY Change -26.51% -32.6%
Other Assets $747.0K $816.0K
YoY Change 26.61% 36.68%
Total Long-Term Assets $63.81M $64.67M
YoY Change -9.35% -10.6%
TOTAL ASSETS
Total Short-Term Assets $115.2M $111.8M
Total Long-Term Assets $63.81M $64.67M
Total Assets $179.0M $176.5M
YoY Change -8.23% -8.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.224M $4.400M
YoY Change -18.63% -14.16%
Accrued Expenses $8.385M $6.635M
YoY Change -4.31% 2.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.78M $13.07M
YoY Change -8.97% -8.06%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $48.00K $56.00K
YoY Change
Total Long-Term Liabilities $48.00K $2.023M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $14.78M $13.07M
Total Long-Term Liabilities $48.00K $2.023M
Total Liabilities $16.61M $15.09M
YoY Change -11.05% -10.71%
SHAREHOLDERS EQUITY
Retained Earnings $109.2M $108.2M
YoY Change -11.36% -9.92%
Common Stock $53.28M $53.16M
YoY Change 0.23% -2.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $162.4M $161.4M
YoY Change
Total Liabilities & Shareholders Equity $179.0M $176.5M
YoY Change -8.23% -8.02%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $4.072M $6.068M
YoY Change -34.07% 21.75%
Depreciation, Depletion And Amortization $999.0K $1.010M
YoY Change 0.4% 5.1%
Cash From Operating Activities $6.703M $3.065M
YoY Change 81.75% -241.77%
INVESTING ACTIVITIES
Capital Expenditures $208.0K $270.0K
YoY Change -141.77% -84.27%
Acquisitions
YoY Change
Other Investing Activities -$3.446M -$8.479M
YoY Change -329.73% -1513.17%
Cash From Investing Activities -$3.654M -$8.749M
YoY Change -464.67% 683.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.078M -3.077M
YoY Change -36.38% -0.58%
NET CHANGE
Cash From Operating Activities 6.703M 3.065M
Cash From Investing Activities -3.654M -8.749M
Cash From Financing Activities -3.078M -3.077M
Net Change In Cash -29.00K -8.761M
YoY Change -80.41% 37.45%
FREE CASH FLOW
Cash From Operating Activities $6.703M $3.065M
Capital Expenditures $208.0K $270.0K
Free Cash Flow $6.495M $2.795M
YoY Change 55.16% -172.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13437000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
13437000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16110000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
16110000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12381000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12307000
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001049606
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13905
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
COMPX INTERNATIONAL INC.
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
57-0981653
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5430 LBJ Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75240-2620
CY2023Q1 dei City Area Code
CityAreaCode
972
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
448-1400
CY2023Q1 dei Security12b Title
Security12bTitle
Class A common stock
CY2023Q1 dei Trading Symbol
TradingSymbol
CIX
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSEAMER
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12307157
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26748000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17987000
CY2022Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
33147000
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
42963000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17840000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18681000
CY2022Q4 us-gaap Inventory Net
InventoryNet
31290000
CY2023Q1 us-gaap Inventory Net
InventoryNet
30235000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2136000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1950000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
111161000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
111816000
CY2022Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
13200000
CY2023Q1 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
12200000
CY2022Q4 us-gaap Goodwill
Goodwill
23742000
CY2023Q1 us-gaap Goodwill
Goodwill
23742000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
590000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
816000
CY2022Q4 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
37532000
CY2023Q1 us-gaap Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment
AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
36758000
CY2022Q4 us-gaap Land
Land
5390000
CY2023Q1 us-gaap Land
Land
5390000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23181000
CY2023Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
23181000
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
74113000
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
74376000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
722000
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
399000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
103406000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
103346000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74712000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75432000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28694000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27914000
CY2022Q4 us-gaap Assets
Assets
177387000
CY2023Q1 us-gaap Assets
Assets
176488000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15618000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11035000
CY2022Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
1035000
CY2023Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
2033000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16653000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
13068000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2230000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1967000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
68000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
56000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2298000
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2023000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53155000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
53155000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
105175000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
108166000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-17000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-47000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
158436000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
161397000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177387000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176488000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42050000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41151000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
29970000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28447000
CY2022Q1 us-gaap Gross Profit
GrossProfit
12080000
CY2023Q1 us-gaap Gross Profit
GrossProfit
12704000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5774000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5664000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6306000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7040000
CY2022Q1 cix Interest Income From Related Party And Dividend Income
InterestIncomeFromRelatedPartyAndDividendIncome
214000
CY2023Q1 cix Interest Income From Related Party And Dividend Income
InterestIncomeFromRelatedPartyAndDividendIncome
947000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6520000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7987000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1536000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1919000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4984000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6068000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
30000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4984000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6038000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.49
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12381000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12307000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
173088000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
4984000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3095000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
174977000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
158436000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
6068000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.25
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3077000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
30000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
161397000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
4984000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
6068000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
961000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1010000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-231000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-250000
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-56000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
336000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2213000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
842000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2490000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1012000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3055000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4543000
CY2022Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
862000
CY2023Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
998000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1036000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
52000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2162000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3065000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1717000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
270000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
13479000
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
4000000
CY2022Q1 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
7700000
CY2023Q1 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
7800000
CY2022Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
7100000
CY2023Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
6800000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1117000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8749000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3095000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3077000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6374000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8761000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76579000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26748000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
70205000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17987000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
904000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1171000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42050000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41151000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6306000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
255000
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
235000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
243000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
219000
CY2022Q4 cix Accrued Customer Tooling Cost
AccruedCustomerToolingCost
135000
CY2023Q1 cix Accrued Customer Tooling Cost
AccruedCustomerToolingCost
181000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7040000
CY2022Q1 cix Interest Income From Related Party And Dividend Income
InterestIncomeFromRelatedPartyAndDividendIncome
214000
CY2023Q1 cix Interest Income From Related Party And Dividend Income
InterestIncomeFromRelatedPartyAndDividendIncome
947000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6520000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7987000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
70000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
70000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17840000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18681000
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6245000
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6014000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19983000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
19337000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5062000
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4884000
CY2022Q4 us-gaap Inventory Net
InventoryNet
31290000
CY2023Q1 us-gaap Inventory Net
InventoryNet
30235000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10489000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5208000
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
279000
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
449000
CY2022Q4 cix Advances From Customers
AdvancesFromCustomers
298000
CY2023Q1 cix Advances From Customers
AdvancesFromCustomers
256000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
382000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
562000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15618000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11035000
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1369000
CY2023Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1677000
CY2022Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
196000
CY2023Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
240000
CY2022Q1 cix Income Tax Reconciliation Foreign Derived Intangible Income Benefit
IncomeTaxReconciliationForeignDerivedIntangibleIncomeBenefit
-33000
CY2023Q1 cix Income Tax Reconciliation Foreign Derived Intangible Income Benefit
IncomeTaxReconciliationForeignDerivedIntangibleIncomeBenefit
-24000
CY2022Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
4000
CY2023Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
26000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1536000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1919000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1536000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1919000
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-13000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1536000
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1906000
CY2023Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
523647

Files In Submission

Name View Source Status
cik-20230331_lab.xml Edgar Link unprocessable
0001558370-23-007663-index-headers.html Edgar Link pending
0001558370-23-007663-index.html Edgar Link pending
0001558370-23-007663.txt Edgar Link pending
0001558370-23-007663-xbrl.zip Edgar Link pending
cik-20230331.xsd Edgar Link pending
cik-20230331x10q.htm Edgar Link pending
cik-20230331xex31d1.htm Edgar Link pending
cik-20230331xex31d2.htm Edgar Link pending
cik-20230331xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cik-20230331_cal.xml Edgar Link unprocessable
cik-20230331_def.xml Edgar Link unprocessable
cik-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cik-20230331x10q_htm.xml Edgar Link completed